Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Marc R Barnard"'
Autor:
Hung Chang, Ivan B Yanachkov, Edward J Dix, Milka Yanachkova, Youfu Li, Marc R Barnard, George E Wright, Alan D Michelson, Andrew L Frelinger
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94780 (2014)
Diadenosine tetraphosphate (Ap4A), a constituent of platelet dense granules, and its P1,P4-dithio and/or P2,P3-chloromethylene analogs, inhibit adenosine diphosphate (ADP)-induced platelet aggregation. We recently reported that these compounds antago
Externí odkaz:
https://doaj.org/article/874ef7e91dfb4fdb80321881bbbe4d83
Autor:
Frank A J L Scheer, Alan D Michelson, Andrew L Frelinger, Heather Evoniuk, Erin E Kelly, Mary McCarthy, Lauren A Doamekpor, Marc R Barnard, Steven A Shea
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24549 (2011)
Platelets are involved in the thromboses that are central to myocardial infarctions and ischemic strokes. Such adverse cardiovascular events have day/night patterns with peaks in the morning (~9 AM), potentially related to endogenous circadian clock
Externí odkaz:
https://doaj.org/article/5c6e187182134da1962b88c42b0d7713
Autor:
James B. Bussel, Michelle A. Berny-Lang, Emily Leven, Marc R. Barnard, W. Beau Mitchell, Alan D. Michelson, Andrew L. Frelinger, Hannah Tamary, Anja J. Gerrits, Sophie L. Brigstocke, Shoshana Revel-Vilk, Sabrina L. Carmichael
Publikováno v:
Blood. 126:1367-1378
Because Wiskott-Aldrich syndrome (WAS) and X-linked thrombocytopenia (XLT) patients have microthrombocytopenia, hemorrhage is a major problem. We asked whether eltrombopag, a thrombopoietic agent, would increase platelet counts, improve platelet acti
Publikováno v:
American Journal of Veterinary Research. 76:328-337
OBJECTIVE To determine whether critically ill dogs had increased platelet activation and whether the proportion of activated platelets correlated with severity of illness. ANIMALS 82 dogs in the intensive care unit of a veterinary teaching hospital a
Autor:
Andrew L. Frelinger, Alan D. Michelson, Joseph A. Jakubowski, Julie K. Brooks, Sabrina L. Zayas, Matthew M. Heeney, Michelle A. Berny-Lang, Marc R. Barnard
Publikováno v:
Platelets. 25:27-35
Abstract 5147 Platelet activation/aggregation in sickle cell disease (SCD) may promote tissue ischemia, suggesting antiplatelet therapy may be useful. However, assessing platelet function and the effect of antiplatelet therapy in blood from SCD patie
Autor:
Sai Nudurupati, Andrew L. Frelinger, Julie K. Brooks, Jingtao Wu, Ronald D. Lee, Michael Lampa, Anu Nigam, Marc R. Barnard, Darcy Mulford, Deepak L. Bhatt, Alan D. Michelson
Publikováno v:
Journal of the American College of Cardiology. 61:872-879
Abstract 4356 Background: Platelet inhibition by clopidogrel is highly variable. Patients with reduced inhibition have increased risk for major adverse cardiovascular events. The aim of this study was to determine whether known genetic, drug, dietary
Publikováno v:
Current Protocols in Cytometry
In inflammatory and thrombotic syndromes, platelets aggregate with circulating leukocytes, especially monocytes and neutrophils. This leukocyte-platelet aggregate formation is initiated primarily through platelet surface expression of P-selectin (CD6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e72b733a6cc0711fee4cf68fb486ecc
https://doi.org/10.1002/cpcy.8
https://doi.org/10.1002/cpcy.8
Autor:
Mark I. Furman, Alan D. Michelson, Marc R. Barnard, Shilpa Rahangdale, Victor Novack, Atul Malhotra, Andrew L. Frelinger, KE Stevenson, Susie Yim Yeh
Publikováno v:
Journal of Clinical Sleep Medicine. :172-178
Objectives:Literature regarding platelet function in obstructive sleep apnea (OSA) has considerable limitations. Given the central role of platelets in atherothrombosis and the known cardiovascular...
Autor:
Andrew L. Frelinger, Karin Przyklenk, Hussien A. Al-Shamma, Michael Morgan, Matthew D. Linden, YouFu Li, Marc R. Barnard, John W. Adams, Alan D. Michelson, Peter Whittaker
Publikováno v:
Journal of Thrombosis and Haemostasis. 8:331-340
Release of serotonin and activation of serotonin 5HT2A receptors on platelet surfaces is a potent augmentative stimulus for platelet aggregation. However, earlier-generation serotonin receptor antagonists were not successfully exploited as antiplatel
Autor:
Andrew L. Frelinger, YouFu Li, Marc R. Barnard, Marsha L. Fox, Mark I. Furman, Douglas J. Christie, Matthew D. Linden, Alan D. Michelson
Publikováno v:
Circulation. 120:2586-2596
Background— Poor clinical outcome in aspirin-treated patients has been termed aspirin resistance and may result from inadequate inhibition of platelet cyclooxygenase-1 (COX-1) by aspirin. The objectives of this study were to determine prospectively